This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
FDA approves first drug for spinal muscular atrophy
The U.S. Food and Drug Administration has approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic
